Rapidemic
PrivateLast Round
Grant
Sep 25, 2025
Total Funding Raised
$811,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rapidemic is a diagnostic equipment company that develops ultrarapid, power-free molecular diagnostic tests for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rapidemic Comparables
Compare Rapidemic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExGen Dx | 88% | |
| Fuse Diagnostics | 82% | |
| Selfdiagnostics | 81% | |
Rapidemic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 25, 2025 | ||||
| Grant | Jun 10, 2023 | ||||
| Grant | Jan 14, 2023 | ||||
| Grant | Jan 1, 2023 | ||||
| Pre Seed | Dec 13, 2021 |
Key People
Founding team and executive leadership
Rapidemic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherlands Organization for Scientific Research | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Graduate Entrepreneur | Pre Seed |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 15, 2026
Grew 44% QoQ from 9 to 13 employees.
- Sep 25, 2025
$2.7M grant from the Bill & Melinda Gates Foundation.
Rapidemic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rapidemic's valuation, stock price, and market status.